ClinicalTrials.Veeva

Menu

Renal Tumour Imaging Using MRI (RIM)

University College London (UCL) logo

University College London (UCL)

Status

Active, not recruiting

Conditions

MRI
Small Renal Mass
Renal Cancer
Kidney Cancers

Treatments

Diagnostic Test: MRI

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study investigates whether new types of MRI scans can tell the difference between different kidney tumours before surgery. Currently, imaging scans can detect kidney tumours and their size, but they aren't effective at determining the tumour type or its aggressiveness. Biopsies are an option, but they are invasive and may miss important cancerous cells. The aim is to use imaging to determine which tumours are aggressive so they can be treated early while avoiding unnecessary treatment of benign tumours.

Patients with small renal tumours (≤ 7 cm) who meet the other inclusion and exclusion criteria will be asked to have an additional MRI scan at University College London Hospital prior to surgery.

The imaging findings will be compared to the histology result from the removed tumour. In 10 patients the histology will be targeted to a specific location in the tumour based on the imaging. 10 patients will undergo a repeat MRI <14 d apart to test whether the MRI scans can give the same answer twice (the test repeatability).

The study is expected to run for 24 months and is funded by NIHR.

The chief investigator for the study is Dr Richard Hesketh (rhesketh@ucl.ac.uk).

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Aged 18 and over
  2. Confirmed renal tumour ≤ 7 cm planned for surgical resection
  3. Willing and able to provide written informed consent
  4. Able to lie supine for the duration of an MRI

Exclusion criteria

  1. Contraindication to MRI e.g., cardiac pacemaker
  2. Contraindication to MR contrast agents
  3. Pregnancy
  4. Breastfeeding
  5. Deranged renal function (eGFR <30) in the last three months.
  6. Previous treatment of the renal tumour e.g., ablation, radiotherapy

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 3 patient groups

Histological characterisation of renal tumours
No Intervention group
Description:
Histological samples of ten patients with tumour histology will be retreived from the Royal Free Hospital Biobank. Slides will be stained using H\&E and CD34 and cell size, stromal space and vascularity will be estimated and used to inform diffusion weighted imaging models.
Comparison of microstructural MRI to histology
Experimental group
Description:
10 patients with small renal tumours will undergo microstructural MRI. Following MRI the tumours will be surgically resected. The MRI will be co-registered with histology. The degree of correlation between the MRI and underlying histology will be determined.
Treatment:
Diagnostic Test: MRI
Repeatability of MRI of small renal masses
Experimental group
Description:
The repeatability of the MRI scan of the small renal mass will be determined by participants undergoing a repeat MRI examination shortly after the first (within 14 d) on the same scanner.
Treatment:
Diagnostic Test: MRI

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems